The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure

The Stroke Prevention War: DOAC vs Warfarin vs LAA Device Closure

At Piedmont Heart’s Napa Valley Cardiology Conference, Dr. Thomas Deering takes a look at the history, scientific and market data and clinical considerations for each stroke reduction therapy. Learn more at http://www.piedmont.org/heartlearning http://www.piedmont.org/napa